Wall Street Pressure May Stop Next Cancer Drug from Being Made

Imagine if the cure for cancer was never discovered because investors wanted faster profits. This might actually be happening right now.

Activist investors (wealthy funds that buy parts of companies to change how they operate) are increasingly targeting pharmaceutical companies. While this often makes stock prices go up, it could be bad news for patients waiting for new medicines.

Here's what's happening:

• Drug development takes 10-20 years and costs billions of dollars • Activist investors want profits in 2-3 years, not decades • When these investors pressure drug companies, the companies stop working on risky breakthrough drugs • Instead, they focus on "me-too" drugs (copies of existing medicines that are easier to make)

Why this matters: The most important medicines in history - like antibiotics or cancer treatments - came from risky, long-term research. If companies only make copycat drugs to please investors, we might miss the next life-saving breakthrough.

Think of it like this: Would you rather have 10 slightly different headache pills, or one cure for Alzheimer's? When Wall Street pushes for quick profits, we get more headache pills and fewer potential cures.

The hidden cost: While investors celebrate higher stock prices today, patients tomorrow might not have access to medicines that could have saved their lives. The pressure for quick profits is literally changing what diseases get cured.

This is an AI-generated summary. Read the original article at: https://www.marketwatch.com/story/could-pressure-to-make-money-faster-kill-the-next-lifesaving-pill-55e3dd27?mod=mw_rss_topstories